As Mike Schuster nears the three-year anniversary of his diagnosis with glioblastoma, he’s already doubled the life expectancy for patients with the deadly cancer.
Agreement will expand clinical trials of glioblastoma drug
OMRF’s biomarker discoveries could bring new therapies for beating gliomas.
OMRF, Stephenson Cancer Center begin tests of experimental compound
Cutting off avenues for growth is key to killing tumors.
Major state donors are helping expand cancer research and facilities.